Chongchai et al.’s study in 2024 [85] also employed TRAIL-based gene therapy by delivering the sTRAIL transgene (secreted form of TRAIL) to target tumor cells, only the study explored the effect on chondrosarcoma. The gene discussed is TNFSF10; the disease is neoplasm.